Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Characterization of selective and potent PI3Kd inhibitor (PI3KDIN- 015) for B-Cell malignances.

Characterization of selective and potent PI3Kd inhibitor (PI3KDIN- 015) for B-Cell malignances. Oncotarget. 2016 May 31; 7(22):32641-51.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.